dicominfo function (MathWorks Inc)
MathWorks Inc is a verified supplier 
90
Structured Review
MathWorks Inc
dicominfo function
Dicominfo Function, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dicominfo+function+in/pm37318259-48-3-24
Average 90 stars, based on 1 article reviews
Dicominfo Function, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dicominfo+function+in/pm37318259-48-3-24
Average 90 stars, based on 1 article reviews
dicominfo function - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Imaging:Article Title: Diagnostic consistency of cases from ADNI cohort metadata: methodological considerations. Article Snippet: Alzheimer’s Disease Neuroimaging Initiative (ADNI) has established the gold standard for the development and formalization of methodologies for investigating neuroimaging, genetic, and blood biomarkers for the study of Alzheimer’s disease (AD), mild cognitive impairment (MCI), and the healthy aging brain (Weiner et al., 2015).. Since 2004, ADNI has (1) developed standardized biomarkers for use in clinical trial subject selection and for proxy outcome measures; (2) provided uniform neuroimaging protocols for use in multicenter trials; (3) initiated a global network of ADNI sites as well as international brain disease research programs based on the ADNI model; (4) spawned affiliated programs investigating traumatic brain injury, post-traumatic stress disorder, and depression as risk factors for AD in armed forces personnel; (5) generated data spawning hundreds of peer-reviewed publications concerning identification of novel AD risk alleles linking neuroimaging biomarkers and AD progression (Weiner et al., 2017); and (6) stimulated new public-private partnerships for the development of biomarkers in Parkinson’s disease, multiple sclerosis, and other brain diseases.. Most importantly, through a generous commitment to open availability of its data, ADNI has provided a rich and valuable resource to researchers (Toga and Crawford, 2010). Software:Article Title: Diagnostic consistency of cases from ADNI cohort metadata: methodological considerations. Article Snippet: Alzheimer’s Disease Neuroimaging Initiative (ADNI) has established the gold standard for the development and formalization of methodologies for investigating neuroimaging, genetic, and blood biomarkers for the study of Alzheimer’s disease (AD), mild cognitive impairment (MCI), and the healthy aging brain (Weiner et al., 2015).. Since 2004, ADNI has (1) developed standardized biomarkers for use in clinical trial subject selection and for proxy outcome measures; (2) provided uniform neuroimaging protocols for use in multicenter trials; (3) initiated a global network of ADNI sites as well as international brain disease research programs based on the ADNI model; (4) spawned affiliated programs investigating traumatic brain injury, post-traumatic stress disorder, and depression as risk factors for AD in armed forces personnel; (5) generated data spawning hundreds of peer-reviewed publications concerning identification of novel AD risk alleles linking neuroimaging biomarkers and AD progression (Weiner et al., 2017); and (6) stimulated new public-private partnerships for the development of biomarkers in Parkinson’s disease, multiple sclerosis, and other brain diseases.. Most importantly, through a generous commitment to open availability of its data, ADNI has provided a rich and valuable resource to researchers (Toga and Crawford, 2010). |